Xenetic Biosciences, Inc. (XBIO)
Chart Events
Performance Outlook
| Previous Close | 0.9144 |
| Open | 0.8900 |
| Bid | 0.8300 x 1300 |
| Ask | 0.8306 x 900 |
| Day's Range | 0.8200 - 0.8917 |
| 52 Week Range | 0.4400 - 1.8500 |
| Volume | 162,110 |
| Avg. Volume | 287,195 |
| Market Cap | 5.225M |
| Beta (5Y Monthly) | 2.41 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -2.4470 |
| Earnings Date | Aug 13, 2020 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 2.25 |
Fair Value
Related Research
- ACCESSWIRE
Xenetic Biosciences, Inc. to Present at the H.C. Wainwright 22nd Annual Global Investment Conference
Live video webcast with CEO, Jeffrey Eisenberg, on Wednesday, September 16th at 12:00 PM EDTFRAMINGHAM, MA / ACCESSWIRE / September 9, 2020 / Xenetic Biosciences, Inc.
- Benzinga
Overview Of Value Stocks In The Healthcare Sector
Understanding Value Stocks A value stock traditionally has a lower price when compared to stock prices of companies in the same industry. This indicates that the company may be undervalued, as investors are not expressing as much interest in such companies. The most commonly used way to check for value is with the price-to-earnings multiple, or P/E. A low P/E multiple is a good indication that the stock is undervalued.Below is a list of notable value stocks in the healthcare sector: 1. Cronos Group (NASDAQ: CRON) - P/E: 2.57 2. Viveve Medical (NASDAQ: VIVE) - P/E: 0.08 3. Brookdale Senior Living (NYSE: BKD) - P/E: 6.3 4. Five Star Senior Living (NASDAQ: FVE) - P/E: 3.92 5. Xenetic Biosciences (NASDAQ: XBIO) - P/E: 0.74Cronos Group saw a decrease in earnings per share from 0.2 in Q1 to -0.19 now. Cronos Group does not have a dividend yield, which investors should be aware of when considering holding onto such a stock.This quarter, Viveve Medical experienced an increase in earnings per share, which was -0.82 in Q1 and is now -0.45. Viveve Medical does not have a dividend yield, which investors should be aware of when considering holding onto such a stock.Brookdale Senior Living has reported Q2 earnings per share at -0.65, which has decreased by 822.22% compared to Q1, which was 0.09. Brookdale Senior Living does not have a dividend yield, which investors should be aware of when considering holding onto such a stock.Most recently, Five Star Senior Living reported earnings per share at 0.1, whereas in Q1 earnings per share sat at -0.55. Five Star Senior Living does not have a dividend yield, which investors should be aware of when considering holding onto such a stock.Most recently, Xenetic Biosciences reported earnings per share at -0.15, whereas in Q1 earnings per share sat at -0.19. Xenetic Biosciences does not have a dividend yield, which investors should be aware of when considering holding onto such a stock.The Significance: A value stock may need some time to rebound from its undervalued position. The risk of investing in a value stock is that this emergence may never materialize.See more from Benzinga * 5 Value Stocks To Watch In The Real Estate Sector * A Look Into Catalent's Debt * Fastenal: Debt Insights(C) 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
- ACCESSWIRE
Xenetic Biosciences, Inc. Reports Second Quarter 2020 Financial Results and Provides Corporate Update
\\- Successfully established two strategic academic collaborations in Q2 2020 to advance development of XCARTâ„¢, its differentiated CAR T therapy platform - \\- Strengthened panel of experts on the Scientific Advisory Board, bringing valuable expertise across all phases of preclinical and clinical development -FRAMINGHAM, MA / ACCESSWIRE / August 13, 2020 / Xenetic Biosciences, Inc.
